| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Prasad Raju is a Chief Financial Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $816K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 3,708 | $46.78 | $173,460.24 | -19.2% | - | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 9,869 | $48.26 | $476,277.94 | -23.8% | - | - | |
| Jan 6, 2026 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 29,700 | $60.16 | $1,786,635.87 | -44.6% | -15.5% | - | |
| Dec 22, 2025 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sell | 10,000 | $55.95 | $559,548.75 | -26.5% | -19.0% | - | |
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 2,197 | $41.23 | $90,582.31 | -11.6% | +7.4% | +12.2% | |
| Mar 17, 2025 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 3,762 | $41.80 | $157,251.60 | -22.8% | -2.9% | +17.0% | |
| Mar 15, 2024 | CRSP Crispr Therapeutics AG | Chief Financial Officer | Sale+OE | 3,524 | $72.69 | $256,159.56 | -35.2% | -10.5% | -42.3% |